hypogonadism; oral-t; kyzatrex; mens health

Shalin Shah is the CEO of Marius Pharmaceuticals, where he leads the development of novel therapies for testosterone deficiency and metabolic health. His background spans finance, private equity, and pharmaceutical strategy, with a focus on patient-centered innovation and education around...